P2.01-100 Different Genetic Mutations Enriched in Circulating Tumor DNA Predict Different Metastatic Sites in Lung Adenocarcinoma Patients

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1154
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P2.01-107 Analysis of Mutation Detection by ctDNA on the Basis of Metastatic Sites in Lung Adenocarcinoma Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Landscape of Somatic Mutations in Different Subtypes of Advanced Breast Cancer With Circulating Tumor DNA Analysis

Scientific Reports
Multidisciplinary
2017English

Rare Metastatic Sites of a Lung Adenocarcinoma

Cureus
2018English

Circulating Tumor DNA Detection in Lung Cancer Patients Before and After Surgery

Scientific Reports
Multidisciplinary
2016English

P2.01-60 Clinical Utility of Circulating Tumor Cell (CTC) Analysis Using Target Selectorâ„¢ in Metastatic NSCLC Chemotherapy Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.01-106 a Comparative Analysis of Genomic Alterations by Tumor Tissue and Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Newly Identified Biomarkers for Detecting Circulating Tumor Cells in Lung Adenocarcinoma

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

Circulating Tumor DNA Detection in Head and Neck Cancer: Evaluation of Two Different Detection Approaches

Oncotarget
Oncology
2017English

Circulating Tumor DNA to Monitor Treatment Response and Detect Acquired Resistance in Patients With Metastatic Melanoma

Oncotarget
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy